Insider Trading activities at Trevi Therapeutics, Inc. (TRVI)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Trevi Therapeutics, Inc. (TRVI) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Trevi Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1563880.

Total stock buying since 2019: $381,350,989.
Total stock sales since 2019: $4,063,338.
Total stock option exercises since 2019: $710,246.


28 insiders reported insider trading activities at Trevi Therapeutics, Inc. (TRVI):
Insider trading activities of Makhzoumi Mohamad
Insider trading activities of Sonsini Peter W.
Insider trading activities of Heffernan Michael Thomas
Insider trading activities of Aperture Ventures Iv Management, Llc
Insider trading activities of Walker Paul Edward
Insider trading activities of Mfic V, Llc
Insider trading activities of Agger Mette Kirstine
Insider trading activities of Makower Joshua
Insider trading activities of Barris Peter J
Insider trading activities of Delfini Lisa
Insider trading activities of Lundbeckfond Invest A/s
Insider trading activities of Richard King Mellon Foundation
Insider trading activities of Sandell Scott D
Insider trading activities of Mitsak Anna Guyer
Insider trading activities of Nea 16 Gp, Llc
Insider trading activities of Baskett Forest
Insider trading activities of Simon Farrell
Insider trading activities of Mott David M
Insider trading activities of Coulter James G
Insider trading activities of Florence Anthony A. Jr.
Insider trading activities of Sciascia Thomas
Insider trading activities of Behbahani Ali
Insider trading activities of Winkelried Jon
Insider trading activities of Good Jennifer L
Insider trading activities of Galletta Christopher
Insider trading activities of Meeker David P
Insider trading activities of Vanlent Anne
Insider trading activities of Chang Carmen

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Trevi Therapeutics, Inc. (TRVI).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 89,207 $616,219 126,457 $300,714
2024 0 $0 201,069 $570,435 233,748 $373,342
2023 0 $0 14,243 $33,467 70,832 $36,190
2022 30,326,838 $57,620,989 1,000,000 $2,828,217 0 $0
2021 16,666,668 $0 0 $0 0 $0
2020 0 $0 5,640 $15,000 0 $0
2019 32,373,000 $323,730,000 0 $0 0 $0

Table 2. Monthly summary of insider trading at Trevi Therapeutics, Inc. (TRVI).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-03 0 $0 89,207 $616,219 120,457 $297,648
2025-01 0 $0 0 $0 6,000 $3,066
2024-12 0 $0 0 $0 15,000 $7,665
2024-09 0 $0 61,180 $188,553 61,180 $87,486
2024-08 0 $0 52,556 $149,454 52,556 $75,153
2024-05 0 $0 87,333 $232,428 105,012 $203,038
2023-10 0 $0 785 $1,585 2,292 $1,171
2023-09 0 $0 711 $1,564 2,291 $1,170
2023-08 0 $0 682 $1,609 2,292 $1,171
2023-07 0 $0 687 $1,607 2,292 $1,171
2023-06 0 $0 610 $1,610 8,541 $4,363
2023-05 0 $0 562 $1,624 2,291 $1,170
2023-04 0 $0 840 $1,544 2,292 $1,171
2023-03 0 $0 892 $1,563 21,041 $10,751
2023-02 0 $0 8,474 $20,761 27,500 $14,052
2022-07 0 $0 500,000 $1,443,836 0 $0
2022-06 0 $0 475,966 $1,318,238 0 $0
2022-05 0 $0 600 $1,620 0 $0
2022-04 30,326,838 $57,620,989 23,434 $64,523 0 $0
2021-10 16,666,668 $0 0 $0 0 $0
2020-04 0 $0 5,640 $15,000 0 $0
2019-05 32,373,000 $323,730,000 0 $0 0 $0

Table 3. Detailed insider trading at Trevi Therapeutics, Inc. (TRVI)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-03-25 Sciascia Thomas (Chief Scientific Officer) Sale 2,631 6.60 17,364
2025-03-25 Sciascia Thomas (Chief Scientific Officer) Option Ex 2,631 1.43 3,762
2025-03-21 Good Jennifer L (President & CEO) Sale 5,263 6.58 34,625
2025-03-21 Good Jennifer L (President & CEO) Option Ex 5,263 1.43 7,526
2025-03-10 Simon Farrell (Chief Commercial Officer) Sale 81,313 6.94 564,230
2025-03-10 Simon Farrell (Chief Commercial Officer) Option Ex 112,563 2.54 286,360
2025-01-08 Delfini Lisa (Chief Financial Officer) Option Ex 5,000 .51 2,555
2025-01-07 Delfini Lisa (Chief Financial Officer) Option Ex 1,000 .51 511
2024-12-13 Galletta Christopher (See Remarks) Option Ex 15,000 .51 7,665
2024-09-09 Good Jennifer L (President & CEO) Sale 1,840 3.04 5,586
2024-09-09 Good Jennifer L (President & CEO) Option Ex 1,840 1.43 2,631
2024-09-06 Good Jennifer L (President & CEO) Sale 4,219 3.03 12,783
2024-09-06 Good Jennifer L (President & CEO) Option Ex 4,219 1.43 6,033
2024-09-05 Good Jennifer L (President & CEO) Sale 40,277 3.11 125,301
2024-09-05 Good Jennifer L (President & CEO) Option Ex 40,277 1.43 57,596
2024-09-04 Good Jennifer L (President & CEO) Sale 10,981 3.02 33,206
2024-09-04 Good Jennifer L (President & CEO) Option Ex 10,981 1.43 15,702
2024-09-03 Good Jennifer L (President & CEO) Sale 3,863 3.02 11,677
2024-09-03 Good Jennifer L (President & CEO) Option Ex 3,863 1.43 5,524
2024-08-27 Meeker David P Sale 4,555 2.93 13,350
2024-08-27 Meeker David P Option Ex 4,555 1.43 6,513
2024-08-19 Sciascia Thomas (Chief Scientific Officer) Sale 16,496 2.96 48,877
2024-08-19 Sciascia Thomas (Chief Scientific Officer) Option Ex 16,496 1.43 23,589
2024-08-16 Sciascia Thomas (Chief Scientific Officer) Sale 18,660 2.76 51,445
2024-08-16 Sciascia Thomas (Chief Scientific Officer) Option Ex 18,660 1.43 26,683
2024-08-15 Sciascia Thomas (Chief Scientific Officer) Sale 12,745 2.79 35,507
2024-08-15 Sciascia Thomas (Chief Scientific Officer) Option Ex 12,745 1.43 18,225
2024-08-14 Sciascia Thomas (Chief Scientific Officer) Sale 100 2.75 275
2024-08-14 Sciascia Thomas (Chief Scientific Officer) Option Ex 100 1.43 143
2024-05-29 Sciascia Thomas (Chief Scientific Officer) Sale 53,368 2.55 136,088
2024-05-29 Sciascia Thomas (Chief Scientific Officer) Option Ex 59,354 2.19 129,985
2024-05-22 Delfini Lisa (Chief Financial Officer) Sale 4,350 2.64 11,484
2024-05-22 Delfini Lisa (Chief Financial Officer) Option Ex 16,043 .51 8,197
2024-05-20 Good Jennifer L (President & CEO) Sale 25,037 2.86 71,580
2024-05-20 Good Jennifer L (President & CEO) Option Ex 25,037 2.19 54,831
2024-05-10 Good Jennifer L (President & CEO) Sale 4,578 2.90 13,276
2024-05-10 Good Jennifer L (President & CEO) Option Ex 4,578 2.19 10,025
2023-10-11 Delfini Lisa (Chief Financial Officer) Sale 785 2.02 1,585
2023-10-11 Delfini Lisa (Chief Financial Officer) Option Ex 2,292 .51 1,171
2023-09-11 Delfini Lisa (Chief Financial Officer) Sale 711 2.20 1,564
2023-09-11 Delfini Lisa (Chief Financial Officer) Option Ex 2,291 .51 1,170
2023-08-11 Delfini Lisa (Chief Financial Officer) Sale 682 2.36 1,609
2023-08-11 Delfini Lisa (Chief Financial Officer) Option Ex 2,292 .51 1,171
2023-07-11 Delfini Lisa (Chief Financial Officer) Sale 687 2.34 1,607
2023-07-11 Delfini Lisa (Chief Financial Officer) Option Ex 2,292 .51 1,171
2023-06-20 Simon Farrell (Chief Commercial Officer) Option Ex 6,250 .51 3,193
2023-06-12 Delfini Lisa (Chief Financial Officer) Sale 610 2.64 1,610
2023-06-12 Delfini Lisa (Chief Financial Officer) Option Ex 2,291 .51 1,170
2023-05-11 Delfini Lisa (Chief Financial Officer) Sale 562 2.89 1,624
2023-05-11 Delfini Lisa (Chief Financial Officer) Option Ex 2,291 .51 1,170
2023-04-11 Delfini Lisa (Chief Financial Officer) Sale 840 1.84 1,544
2023-04-11 Delfini Lisa (Chief Financial Officer) Option Ex 2,292 .51 1,171
2023-03-13 Delfini Lisa (Chief Financial Officer) Sale 892 1.75 1,563
2023-03-13 Delfini Lisa (Chief Financial Officer) Option Ex 2,291 .51 1,170
2023-03-07 Simon Farrell (Chief Commercial Officer) Option Ex 18,750 .51 9,581
2023-02-13 Delfini Lisa (Chief Financial Officer) Sale 8,474 2.45 20,761
2023-02-13 Delfini Lisa (Chief Financial Officer) Option Ex 27,500 .51 14,052
2022-07-05 Winkelried Jon Sale 63,569 3.11 197,826
2022-07-01 Winkelried Jon Sale 436,431 2.85 1,246,010
2022-06-30 Winkelried Jon Sale 429,838 2.77 1,191,940
2022-06-29 Winkelried Jon Sale 46,128 2.74 126,298
2022-05-02 Winkelried Jon Sale 600 2.70 1,620
2022-04-29 Winkelried Jon Sale 16,163 2.75 44,383
2022-04-28 Winkelried Jon Sale 7,271 2.77 20,140
2022-04-11 Chang Carmen (10% Owner) Buy 3,580,526 1.90 6,802,999
2022-04-11 Nea 16 Gp, Llc (10% Owner) Buy 2,631,578 1.90 4,999,998
2022-04-11 Makhzoumi Mohamad (10% Owner) Buy 3,580,526 1.90 6,802,999
2022-04-11 Behbahani Ali (10% Owner) Buy 3,580,526 1.90 6,802,999
2022-04-11 Florence Anthony A. Jr. (10% Owner) Buy 3,580,526 1.90 6,802,999
2022-04-11 Sonsini Peter W. (10% Owner) Buy 3,580,526 1.90 6,802,999
2022-04-11 Walker Paul Edward (10% Owner) Buy 3,580,526 1.90 6,802,999
2022-04-11 Baskett Forest (10% Owner) Buy 2,631,578 1.90 4,999,998
2022-04-11 Sandell Scott D (10% Owner) Buy 3,580,526 1.90 6,802,999
2021-10-18 Chang Carmen (10% Owner) Buy 1,851,852 .00 0
2021-10-18 Nea 16 Gp, Llc (10% Owner) Buy 1,851,852 .00 0
2021-10-18 Makhzoumi Mohamad (10% Owner) Buy 1,851,852 .00 0
2021-10-18 Behbahani Ali (10% Owner) Buy 1,851,852 .00 0
2021-10-18 Florence Anthony A. Jr. (10% Owner) Buy 1,851,852 .00 0
2021-10-18 Sonsini Peter W. (10% Owner) Buy 1,851,852 .00 0
2021-10-18 Walker Paul Edward (10% Owner) Buy 1,851,852 .00 0
2021-10-18 Baskett Forest (10% Owner) Buy 1,851,852 .00 0
2021-10-18 Sandell Scott D (10% Owner) Buy 1,851,852 .00 0
2020-04-03 Chang Carmen (10% Owner) Sale 564 2.66 1,500
2020-04-03 Nea 16 Gp, Llc (10% Owner) Sale 564 2.66 1,500
2020-04-03 Makhzoumi Mohamad (10% Owner) Sale 564 2.66 1,500
2020-04-03 Behbahani Ali (10% Owner) Sale 564 2.66 1,500
2020-04-03 Florence Anthony A. Jr. (10% Owner) Sale 564 2.66 1,500
2020-04-03 Sonsini Peter W. (10% Owner) Sale 564 2.66 1,500
2020-04-03 Walker Paul Edward (10% Owner) Sale 564 2.66 1,500
2020-04-03 Baskett Forest (10% Owner) Sale 564 2.66 1,500
2020-04-03 Sandell Scott D (10% Owner) Sale 564 2.66 1,500
2020-04-03 Makower Joshua (10% Owner) Sale 564 2.66 1,500
2019-05-09 Aperture Ventures Iv Management, Llc (10% Owner) Buy 112,000 10.00 1,120,000
2019-05-09 Mfic V, Llc (10% Owner) Buy 100,000 10.00 1,000,000
2019-05-09 Richard King Mellon Foundation (10% Owner) Buy 100,000 10.00 1,000,000
2019-05-09 Mitsak Anna Guyer (Director) Buy 481,000 10.00 4,810,000
2019-05-09 Chang Carmen (10% Owner) Buy 2,500,000 10.00 25,000,000
2019-05-09 Agger Mette Kirstine (Director) Buy 375,000 10.00 3,750,000
2019-05-09 Nea 16 Gp, Llc (10% Owner) Buy 2,500,000 10.00 25,000,000
2019-05-09 Makhzoumi Mohamad (10% Owner) Buy 2,500,000 10.00 25,000,000
2019-05-09 Behbahani Ali (10% Owner) Buy 2,500,000 10.00 25,000,000
2019-05-09 Lundbeckfond Invest A/s (10% Owner) Buy 375,000 10.00 3,750,000
2019-05-09 Florence Anthony A. Jr. (10% Owner) Buy 2,500,000 10.00 25,000,000
2019-05-09 Sonsini Peter W. (10% Owner) Buy 2,500,000 10.00 25,000,000
2019-05-09 Walker Paul Edward (10% Owner) Buy 2,500,000 10.00 25,000,000
2019-05-09 Heffernan Michael Thomas (Director) Buy 2,500 10.00 25,000
2019-05-09 Meeker David P (Director) Buy 11,250 10.00 112,500
2019-05-09 Baskett Forest (10% Owner) Buy 2,500,000 10.00 25,000,000
2019-05-09 Sandell Scott D (10% Owner) Buy 2,500,000 10.00 25,000,000
2019-05-09 Makower Joshua (10% Owner) Buy 2,500,000 10.00 25,000,000
2019-05-09 Good Jennifer L (See Remarks) Buy 11,250 10.00 112,500
2019-05-09 Vanlent Anne (Director) Buy 5,000 10.00 50,000
2019-05-09 Mott David M (10% Owner) Buy 2,500,000 10.00 25,000,000
2019-05-09 Coulter James G Buy 800,000 10.00 8,000,000
2019-05-09 Barris Peter J (10% Owner) Buy 2,500,000 10.00 25,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of TRVI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Trevi Therapeutics, Inc. (symbol TRVI, CIK number 1563880) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.